₹5633.5036.000.64%(1D)
Performance Stats for Alkem Laboratories
Day Range
Low: ₹5506.00
High: ₹5647.50
52 Week Range
Low: ₹4738.50
High: ₹5933.50
Open Price
5520.50Previous Close
5597.50Volume
74802.00Open Price
5520.50Previous Close
5597.50Volume
74802.00Fundamentals of Alkem Laboratories
ROCE
18.77%
EPS
₹200.88
Dividend Yield
1%
P/E Ratio
27.78
P/B Ratio
4.53
Debt to Equity
0.04
Current Ratio
3.05
Sales Growth
9.65%
Profit Growth
0.05%
EBIT Growth
4.13%
Financials of Alkem Laboratories
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Alkem Laboratories
About Alkem Laboratories
Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company pr...
Read more
Similar Sector Stocks
| Stocks | CMP |
| Aarti Drugs | ₹418.15 1.78% |
| Aarti Pharmalabs | ₹684.2 1.16% |
| Abbott India | ₹27810 0.16% |
| Acutaas Chemicals | ₹3290 0.9% |
Most Viewed Stocks
Open Interest (OI)
Alkem Laboratories Options
| Price | OI | Volume |
Events Related to Alkem Laboratories
AGM
Aug 27, 2026
EGM
Aug 17, 2026
Board Meeting
Aug 14, 2026
Dividend
Aug 7, 2026
Board Meeting
May 28, 2026
News About Alkem Laboratories
Maruti Suzuki, ABB India, Chennai Petro, Alkem Labs, Grasim, Sharda Cropchem Dividends: Last Day To Buy Shares To Qualify
Aug 6, 2026
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal
Jun 3, 2026
Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani Ports
Jun 3, 2026
Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers
Jun 2, 2026
Ashok Leyland to Bharat Dynamics Q4 Results Review — Check Target Prices, Potential Upside, Ratings, Stock Calls By HDFC Securities
May 29, 2026
